[SCHEDULE 13G/A] Utah Medical Products Inc SEC Filing

Rhea-AI Filing Summary

Brandes Investment Partners, L.P. reports beneficial ownership of 271,537 common shares of Utah Medical Products, representing 7.39% of the class as stated in Item 4. The filing shows Brandes holds shared voting and shared dispositive power over these shares and reports no sole voting or dispositive power, indicating it does not exercise unilateral control.

The statement is filed on Schedule 13G/A and classifies the reporting person as IA, PN (investment adviser/portfolio manager). The filer certifies the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Positive

• Reported beneficial ownership of 271,537 shares, a material disclosure above the 5% threshold
• Filer classified as IA, PN, indicating institutional investment and regulatory transparency

Negative

• Inconsistency in percent of class reported within the filing (one section lists 8.4% while Item 4 lists 7.39%)
• No sole voting or dispositive power reported, limiting direct control or influence over corporate decisions

Insights

Financial Analyst

TL;DR: Brandes reports a material passive stake of 271,537 UTMD shares (7.39%), disclosed on Schedule 13G/A.

Brandes' reported stake of 271,537 shares (7.39%) exceeds the 5% reporting threshold and is therefore material to holders of UTMD equity from a disclosure perspective. The filing is a Schedule 13G/A, including the filers certification that the position is held in the ordinary course of business and not to influence control, which typically signals a passive, institutional investment rather than an activist intent. Shared voting and dispositive power is disclosed; there is no sole control.

Corporate Governance Expert

TL;DR: Ownership is material but declared passive; shared voting/dispositive power suggests limited governance influence.

The report classifies Brandes as IA, PN and discloses only shared voting and dispositive power over the 271,537 shares. The signer certifies the holdings are not for the purpose of changing control, reinforcing a passive posture. From a governance standpoint, the position is sizable enough to warrant monitoring by management and investors, but the filing contains no indication of control-seeking activities.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

UTAH MEDICAL PRODUCTS INC

(Name of Issuer)

Common Shares

(Title of Class of Securities)

917488108

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 917488108

1

Names of Reporting Persons

BRANDES INVESTMENT PARTNERS, LP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 271,537.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 271,537.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

271,537.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.4 %

12

Type of Reporting Person (See Instructions)

IA, PN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: UTAH MEDICAL PRODUCTS INC
(b)	Address of issuer's principal executive offices: 7043 S 300 WEST, MIDVALE, UTAH, 84047-1048.
Item 2.
(a)	Name of person filing: Brandes Investment Partners, L.P.
(b)	Address or principal business office or, if none, residence: 4275 Executive Square, 5th Floor, La Jolla, CA 92037
(c)	Citizenship: Delaware
(d)	Title of class of securities: Common Shares
(e)	CUSIP No.: 917488108
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 271,537
(b)	Percent of class: 7.39 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 271,537
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 271,537
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

BRANDES INVESTMENT PARTNERS, LP

Signature:	/s/ Glenn Carlson
Name/Title:	Executive Director
Date:	08/11/2025

FAQ

How many UTMD shares does Brandes Investment Partners report owning?

Brandes reports beneficial ownership of 271,537 common shares of UTMD.

What percentage of UTMD does Brandes own according to the filing?

The filing states the reported holding represents 7.39% of the class in Item 4.

Does Brandes have sole voting or dispositive power over its UTMD shares?

No. The filing shows 0 shares with sole voting or dispositive power and 271,537 shares with shared voting and dispositive power.

Is Brandes seeking to influence control of Utah Medical Products (UTMD)?

The filer certifies the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

What type of SEC statement was filed for UTMD by Brandes?

Brandes filed a Schedule 13G/A reporting its beneficial ownership and related disclosures.